Skip to main content

Human Papillomavirus 9-valent Vaccine, Recombinant 40 ug/.5mL / 60 ug/.5mL / 40 ug/.5mL / 20 ug/.5mL / 20 ug/.5mL / 20 ug/.5mL / 20 ug/.5mL / 20 ug/.5m Medicare Part D Coverage

Brand name: GARDASIL 9
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
100%
of Medicare Part D plans
cover Human Papillomavirus 9-valent Vaccine, Recombinant
5,529 of 5,530 plans
2.3
Avg. formulary tier
$12.00
Median 30-day copay
$0.00–$24.00
Copay range

Formulary Tier Distribution

How Medicare Part D plans classify Human Papillomavirus 9-valent Vaccine, Recombinant. Lower tiers = lower copays.

Tier 1 - Preferred Generic 53%
2,955 plans • avg $0.01/mo
Tier 2 - Generic 1%
32 plans • avg $2.33/mo
Tier 3 - Preferred Brand 31%
1,700 plans • avg $9.22/mo
Tier 4 - Non-Preferred Drug 3%
139 plans
Tier 6 - Select Care 13%
703 plans • avg $0.00/mo

Find the cheapest plan for Human Papillomavirus 9-valent Vaccine, Recombinant

Enter your ZIP code to compare every plan in your area side-by-side.

Compare Plans for Human Papillomavirus 9-valent Vaccine, Recombinant →

Get Human Papillomavirus 9-valent Vaccine, Recombinant Delivered to Your Door

Compare prices and get discounts from trusted online pharmacies

Amazon Pharmacy Hims & Hers GoodRx

DrugCovered may earn commissions from pharmacy purchases. Prices and availability vary. Always consult your doctor before starting or changing medications.

Human Papillomavirus 9-valent Vaccine, Recombinant Medicare Coverage by State

Coverage rates and average costs vary significantly by state. Click a state to see the specific plans available there.

Alabama 100% Arizona 100% Arkansas 100% California 100% Colorado 100% Connecticut 100% Delaware 100% District of Columbia 100% Florida 100% Georgia 100% Hawaii 100% Idaho 100% Illinois 100% Indiana 100% Iowa 100% Kansas 100% Kentucky 100% Louisiana 100% Maine 100% Maryland 100% Massachusetts 100% avg $1.78 Michigan 100% Minnesota 100% Mississippi 100% Missouri 100% Montana 100% Nebraska 100% Nevada 100% New Hampshire 100% New Jersey 100% New Mexico 100% New York 100% North Carolina 100% North Dakota 100% Ohio 100% avg $0.11 Oklahoma 100% Oregon 100% Pennsylvania 100% Puerto Rico 100% Rhode Island 100% South Carolina 100% South Dakota 100% Tennessee 100% Texas 100% Utah 100% Vermont 100% Virginia 100% Washington 100% West Virginia 100% avg $0.25 Wisconsin 100% Wyoming 100%

Related Versions of Human Papillomavirus 9-valent Vaccine, Recombinant

GARDASIL 9 40 ug/.5mL / 60 ug/.5mL / 40 ug/.5mL / 20 ug/.5mL / 20 ug/.5mL / 20 ug/.5mL / 20 ug/.5mL / 20 ug/.5m Brand

Frequently Asked Questions about Human Papillomavirus 9-valent Vaccine, Recombinant

100% of Medicare Part D plans cover Human Papillomavirus 9-valent Vaccine, Recombinant. It is most commonly placed on Tier 2. Coverage varies by plan and geographic area.

The median 30-day copay for Human Papillomavirus 9-valent Vaccine, Recombinant on Medicare Part D is $12.00 at a preferred pharmacy. Costs range from $0.00 to $24.00 depending on the plan.

Human Papillomavirus 9-valent Vaccine, Recombinant is placed on Tier 2 by most Medicare Part D plans. Lower tier numbers generally mean lower copays.

0% of plans require prior authorization for Human Papillomavirus 9-valent Vaccine, Recombinant. Prior authorization means your doctor must confirm the drug is medically necessary before the plan will cover it.

Coverage statistics based on CMS formulary data for plan year 2026. Data updated regularly. Methodology →